265 related articles for article (PubMed ID: 16179569)
1. A new visual rating scale to assess strategic white matter hyperintensities within cholinergic pathways in dementia.
Bocti C; Swartz RH; Gao FQ; Sahlas DJ; Behl P; Black SE
Stroke; 2005 Oct; 36(10):2126-31. PubMed ID: 16179569
[TBL] [Abstract][Full Text] [Related]
2. White Matter Hyperintensities in Mild Cognitive Impairment and Lower Risk of Cognitive Decline.
Nolze-Charron G; Mouiha A; Duchesne S; Bocti C;
J Alzheimers Dis; 2015; 46(4):855-62. PubMed ID: 26402625
[TBL] [Abstract][Full Text] [Related]
3. The effect of ischemic cholinergic damage on cognition in patients with subcortical vascular cognitive impairment.
Kim SH; Kang HS; Kim HJ; Moon Y; Ryu HJ; Kim MY; Han SH
J Geriatr Psychiatry Neurol; 2012 Jun; 25(2):122-7. PubMed ID: 22689705
[TBL] [Abstract][Full Text] [Related]
4. Strategic subcortical hyperintensities in cholinergic pathways and executive function decline in treated Alzheimer patients.
Behl P; Bocti C; Swartz RH; Gao F; Sahlas DJ; Lanctot KL; Streiner DL; Black SE
Arch Neurol; 2007 Feb; 64(2):266-72. PubMed ID: 17296844
[TBL] [Abstract][Full Text] [Related]
5. Simple versus complex assessment of white matter hyperintensities in relation to physical performance and cognition: the LADIS study.
Gouw AA; Van der Flier WM; van Straaten EC; Barkhof F; Ferro JM; Baezner H; Pantoni L; Inzitari D; Erkinjuntti T; Wahlund LO; Waldemar G; Schmidt R; Fazekas F; Scheltens P;
J Neurol; 2006 Sep; 253(9):1189-96. PubMed ID: 16998647
[TBL] [Abstract][Full Text] [Related]
6. Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study.
van der Flier WM; van Straaten EC; Barkhof F; Verdelho A; Madureira S; Pantoni L; Inzitari D; Erkinjuntti T; Crisby M; Waldemar G; Schmidt R; Fazekas F; Scheltens P
Stroke; 2005 Oct; 36(10):2116-20. PubMed ID: 16141425
[TBL] [Abstract][Full Text] [Related]
7. Periventricular white matter hyperintensities and the risk of dementia: a CREDOS study.
Kim S; Choi SH; Lee YM; Kim MJ; Kim YD; Kim JY; Park JH; Myung W; Na HR; Han HJ; Shim YS; Kim JH; Yoon SJ; Kim SY; Kim DK
Int Psychogeriatr; 2015 Dec; 27(12):2069-77. PubMed ID: 26212042
[TBL] [Abstract][Full Text] [Related]
8. Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging.
Gootjes L; Teipel SJ; Zebuhr Y; Schwarz R; Leinsinger G; Scheltens P; Möller HJ; Hampel H
Dement Geriatr Cogn Disord; 2004; 18(2):180-8. PubMed ID: 15211074
[TBL] [Abstract][Full Text] [Related]
9. Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson's disease patients according to cognitive status.
Shin J; Choi S; Lee JE; Lee HS; Sohn YH; Lee PH
J Neurol Neurosurg Psychiatry; 2012 Mar; 83(3):315-21. PubMed ID: 22228726
[TBL] [Abstract][Full Text] [Related]
10. Effect of cholinergic pathway disruption on cortical and subcortical volumes in subcortical vascular cognitive impairment.
Lim JS; Kwon HM; Lee YS
Eur J Neurol; 2020 Jan; 27(1):210-212. PubMed ID: 31444924
[TBL] [Abstract][Full Text] [Related]
11. Differential cholinergic pathway involvement in Alzheimer's disease and subcortical ischemic vascular dementia.
Kim HJ; Moon WJ; Han SH
J Alzheimers Dis; 2013; 35(1):129-36. PubMed ID: 23364137
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the Alzheimer's Disease Assessment Scale Cognitive Subscale and the Vascular Dementia Assessment Scale in differentiating elderly individuals with different degrees of white matter changes. The LADIS Study.
Ylikoski R; Jokinen H; Andersen P; Salonen O; Madureira S; Ferro J; Barkhof F; van der Flier W; Schmidt R; Fazekas F; Scheltens P; Waldemar G; Salvadori E; Pantoni L; Inzitari D; Erkinjuntti T;
Dement Geriatr Cogn Disord; 2007; 24(2):73-81. PubMed ID: 17565216
[TBL] [Abstract][Full Text] [Related]
13. Age-associated leukoaraiosis and cortical cholinergic deafferentation.
Bohnen NI; Müller ML; Kuwabara H; Constantine GM; Studenski SA
Neurology; 2009 Apr; 72(16):1411-6. PubMed ID: 19380700
[TBL] [Abstract][Full Text] [Related]
14. Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study.
van Straaten EC; Fazekas F; Rostrup E; Scheltens P; Schmidt R; Pantoni L; Inzitari D; Waldemar G; Erkinjuntti T; Mäntylä R; Wahlund LO; Barkhof F;
Stroke; 2006 Mar; 37(3):836-40. PubMed ID: 16439704
[TBL] [Abstract][Full Text] [Related]
15. White matter hyperintensities and cognitive dysfunction in Alzheimer disease.
Heo JH; Lee ST; Kon Chu ; Park HJ; Shim JY; Kim M
J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):207-12. PubMed ID: 19433863
[TBL] [Abstract][Full Text] [Related]
16. Visual rating of white matter hyperintensities in Parkinson's disease.
Beyer MK; Aarsland D; Greve OJ; Larsen JP
Mov Disord; 2006 Feb; 21(2):223-9. PubMed ID: 16161159
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging of the brain in patients with pseudoexfoliation syndrome and glaucoma.
Yüksel N; Anik Y; Altintaş O; Onur I; Cağlar Y; Demirci A
Ophthalmologica; 2006; 220(2):125-30. PubMed ID: 16491036
[TBL] [Abstract][Full Text] [Related]
18. Behavioural and psychological symptoms are not related to white matter hyperintensities and medial temporal lobe atrophy in Alzheimer's disease.
Staekenborg SS; Gillissen F; Romkes R; Pijnenburg YA; Barkhof F; Scheltens P; van der Flier WM
Int J Geriatr Psychiatry; 2008 Apr; 23(4):387-92. PubMed ID: 17907266
[TBL] [Abstract][Full Text] [Related]
19. A new classification system for ischemia using a combination of deep and periventricular white matter hyperintensities.
Noh Y; Lee Y; Seo SW; Jeong JH; Choi SH; Back JH; Woo SY; Kim GH; Shin JS; Kim CH; Cho H; Park JS; Lee JM; Hong CH; Kim SY; Lee JH; Kim SY; Park KH; Han SH; Cheong HK; Na DL
J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):636-42. PubMed ID: 23867045
[TBL] [Abstract][Full Text] [Related]
20. A new visual scale to assess white matter hyperintensities within cholinergic pathways.
Pawlak M; Krejza J
Stroke; 2005 Oct; 36(10):2064-5. PubMed ID: 16192460
[No Abstract] [Full Text] [Related]
[Next] [New Search]
